| CAS Number: | 7439-96-5 |
| MDL Number: | MFCD00011111 |
| Molecular Formula: | Mn |
| Molecular Weight: | 54.93 |
| Chemical Formula: | Mn |
| Color and Form: | -325 mesh |
| Note: |
Safety: Hazardous
Physical Characteristics: melting point 1260°C, boiling point 1900°C, density 7.20
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Manganese powder (99.5%) |
| Product Number: | 93-2543 |
| CAS Registry Number: | 7439-96-5 |
| Formula: | Mn |
| EINECS Number: | 231-105-1 |
| Chemical Family: | metal or element |
| Synonym: | None |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 7439-96-5 | 100 | 0.2mg/m3 | 5mg/m3 |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Irritating to skin, eyes and respiratory tract. |
| Primary Routes of Exposure: | Ingestion, inhalation, skin, eyes. |
| Eye Contact: | Causes slight to mild irritation of the eyes. |
| Skin Contact: | Causes slight to mild irritation of the skin. |
| Inhalation: | As a fine dust, may be irritating to the nose, mucous membranes and respiratory tract. |
| Ingestion: | No specific information on the physiological effects of ingestion. |
| Acute Health Effects: | As a fine dust, irritating to skin, eyes and respiratory tract. |
| Chronic Health Effects: | Prolonged exposure to manganese containing dust may produce manganese pneumonitis and manganese poisoning. Symptoms include sleepiness, weakness and emotional disturbances. Equivocal studies have shown manganese may decrease fertility in men. Possible risk of irreversible effects. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | no data |
| Autoignition Temperature: | none |
| Explosion Limits: | no data |
| Extinguishing Medium: | foam or dry powder |
| Special Fire Fighting Procedures: | If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire this material may emit irritating and toxic fumes. |
| Unusual Fire or Explosion Hazards: | Flammable solid. Fine dust mixed with air may be explosive. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite or sodium carbonate and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store in a tightly sealed container. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. |
| Ventilation: | If possible, handle the material in an efficient fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | -325 mesh, gray powder |
| Molecular Weight: | 54.93 |
| Melting Point: | 1260°C |
| Boiling Point: | 1900°C |
| Vapor Pressure: | 1mm (1292°C) |
| Specific Gravity: | 7.20 |
| Odor: | none |
| Solubility in Water: | Insoluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable solid |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | none |
| Incompatibility: | Mineral acids, halogens and oxidizing agents |
| Decomposition Products: | none |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Administration onto the skin (rabbit); Standard Draize test:500 mg/24H. Inhalation (human-man); TCLo:2300 ug/m3. Oral (rat); LD50:9 g/kg. Intraperitoneal (rat); TDLo:180 mg/kg/30D-I. Intramuscular (rat); TDLo:400 mg/kg/1Y-I. |
| Carcinogenic Effects: | Insufficient data |
| Mutagenic Effects: | Possible mutagen |
| Tetratogenic Effects: | No data available |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | No information available |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Metal Powder, Flammable, N.O.S. |
| Hazard Class (CFR): | 4.1 |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | III |
| UN ID Number (CFR): | UN# 3089 |
| Shipping Name (IATA): | Metal Powder, Flammable, N.O.S. |
| Hazard Class (IATA): | 4.1 |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | III |
| UN ID Number (IATA): | UN# 3089 |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory |
| SARA (Title 313): | Reportable under SARA Title 313. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 10/03/2000 |
| Revision Date: | 12/14/2011 |